Trending News
News
News
Eurogentec Launches new Oligo Synthesis Facility
Key facility expands Eurogentec’s global business in the life science research, molecular diagnostic, and clinical laboratory markets.
News
Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists
Companies establish an exclusive, worldwide collaboration with the aim to discover, develop and commercialize autoimmune disease therapies.
News
Cellexus and Groton Collaborate on Use of Automated Sampling with Single-Use Bioreactors
Collaboration uses Groton’s automated sampler with the Cellexus single-use bioreactors for aseptic sample extraction from cell culture.
News
Evotec Acquires Zebrafish Screening Operations of Summit Corporation
The acquisition against £ 0.5 million cash in 2009 expected to add approximately £ 1.5 million revenues in 2010.
News
Evotec to Re-engineer Drug Discovery and Development Operations
Evotec to concentrate all proprietary core research programs at its European operations.
News
Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
Both the companies gain right to exclusively license and/or sublicense a number of albumin fusion proteins in exchange for royalties and other consideration.
News
Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome
Cangene obtains an exclusive license to Maxygen’s MAXY-G34 protein therapeutic for an up-front fee of $500,000.
News
Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich
Collaboration to validate the TECHNOTHROMBIN® thrombin generation assay for Tecan’s Infinite® M200 multimode microplate reader.
News
Thermo Fisher Scientific Event Showcases New Breakthroughs in FAIMS
Attendees presented a number of breakthroughs enabled through their use of the FAIMS technology.
News
Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs
Studies reveal that the extent of CNVs in the dog genome and their association with known and candidate disease genes is similar to mice and humans.
Advertisement